Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping
Open Access
- 16 September 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 24 (11), 1927-1933
- https://doi.org/10.1038/leu.2010.160
Abstract
Immunophenotypic characterization of B-cell chronic lymphoproliferative disorders (B-CLPD) is becoming increasingly complex due to usage of progressively larger panels of reagents and a high number of World Health Organization (WHO) entities. Typically, data analysis is performed separately for each stained aliquot of a sample; subsequently, an expert interprets the overall immunophenotypic profile (IP) of neoplastic B-cells and assigns it to specific diagnostic categories. We constructed a principal component analysis (PCA)-based tool to guide immunophenotypic classification of B-CLPD. Three reference groups of immunophenotypic data files—B-cell chronic lymphocytic leukemias (B-CLL; n=10), mantle cell (MCL; n=10) and follicular lymphomas (FL; n=10)—were built. Subsequently, each of the 175 cases studied was evaluated and assigned to either one of the three reference groups or to none of them (other B-CLPD). Most cases (89%) were correctly assigned to their corresponding WHO diagnostic group with overall positive and negative predictive values of 89 and 96%, respectively. The efficiency of the PCA-based approach was particularly high among typical B-CLL, MCL and FL vs other B-CLPD cases. In summary, PCA-guided immunophenotypic classification of B-CLPD is a promising tool for standardized interpretation of tumor IP, their classification into well-defined entities and comprehensive evaluation of antibody panels.Keywords
This publication has 35 references indexed in Scilit:
- A probabilistic approach for the evaluation of minimal residual disease by multiparameter flow cytometry in leukemic B‐cell chronic lymphoproliferative disordersCytometry Part A, 2008
- Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinationsHaematologica, 2008
- Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry methodHaematologica, 2008
- A multicenter retrospective clinical study of CD5/CD10‐negative chronic B cell leukemiasAmerican Journal of Hematology, 2008
- Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteriaLeukemia, 2007
- Optimizing a Multicolor Immunophenotyping AssayClinics In Laboratory Medicine, 2007
- Influence of 4‐ and 6‐color flow cytometers and acquisition/analysis softwares on the determination of lymphocyte subsets in HIV infectionCytometry Part B: Clinical Cytometry, 2007
- Discriminant function analysis as decision support system for the diagnosis of acute leukemia with a minimal four color screening panel and multiparameter flow cytometry immunophenotypingLeukemia, 2007
- Report on the second Latin American consensus conference for flow cytometric immunophenotyping of hematological malignanciesCytometry Part B: Clinical Cytometry, 2005
- Variability in B-cell antigen expression: implications for the treatment of B-cell lymphomas and leukemias with monoclonal antibodiesThe Hematology Journal, 2001